Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan

Po Chung Ju, Frank Huang Chih Chou, Te Jen Lai, Po Ya Chuang, Yung Jung Lin, Ching Wen Wendy Yang, Chao Hsiun Tang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We aimed at evaluating the relationship between medication and treatment effectiveness in a home care setting among patients with schizophrenia. Patients with schizophrenia hospitalized between 2004 and 2009 with a primary International Classification of Diseases, Ninth Revision, Clinical Modification code of 295 were identified from Psychiatric Inpatient Medical Claims Data released by the National Health Research Institute in Taiwan. Patients who joined the home care program after discharge and were prescribed long-acting injection (LAI) (the LAI group) or oral antipsychotic medications (the oral group) were included as study subjects. The final sample for the study included 810 participants in the LAI group and 945 in the oral group. Logistic regression was performed to examine the independent effect of LAI medication on the risk for rehospitalization within the 12-month observation window after controlling for patient and hospital characteristics and propensity score quintile adjustment. The unadjusted odds ratio for rehospitalization risk was 0.80 (confidence interval, 0.65-0.98) for the LAI group compared to the oral group. The adjusted odds ratio was further reduced to 0.78 (confidence interval, 0.63-0.97). Results remained unchanged when the propensity score quintiles were entered into the regression for further adjustment. In a home care setting, patients treated with long-acting antipsychotic agents are at a significantly lower risk for psychiatric rehospitalization than those treated with oral medication. Consequently, LAI home-based treatment for the prevention of schizophrenia relapse may lead to substantial clinical and economic benefits.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalJournal of Clinical Psychopharmacology
Volume34
Issue number1
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Home Care Services
Taiwan
Schizophrenia
Injections
Social Adjustment
Propensity Score
Antipsychotic Agents
Psychiatry
Odds Ratio
Confidence Intervals
International Classification of Diseases
Secondary Prevention
Inpatients
Logistic Models
Economics
Observation
Health

Keywords

  • Home care
  • Logistic regression
  • Long-acting injection
  • Risperidone
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan. / Ju, Po Chung; Chou, Frank Huang Chih; Lai, Te Jen; Chuang, Po Ya; Lin, Yung Jung; Yang, Ching Wen Wendy; Tang, Chao Hsiun.

In: Journal of Clinical Psychopharmacology, Vol. 34, No. 1, 02.2014, p. 23-29.

Research output: Contribution to journalArticle

Ju, Po Chung ; Chou, Frank Huang Chih ; Lai, Te Jen ; Chuang, Po Ya ; Lin, Yung Jung ; Yang, Ching Wen Wendy ; Tang, Chao Hsiun. / Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan. In: Journal of Clinical Psychopharmacology. 2014 ; Vol. 34, No. 1. pp. 23-29.
@article{e940dafbb4bd4030ba4e982155a07f85,
title = "Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan",
abstract = "We aimed at evaluating the relationship between medication and treatment effectiveness in a home care setting among patients with schizophrenia. Patients with schizophrenia hospitalized between 2004 and 2009 with a primary International Classification of Diseases, Ninth Revision, Clinical Modification code of 295 were identified from Psychiatric Inpatient Medical Claims Data released by the National Health Research Institute in Taiwan. Patients who joined the home care program after discharge and were prescribed long-acting injection (LAI) (the LAI group) or oral antipsychotic medications (the oral group) were included as study subjects. The final sample for the study included 810 participants in the LAI group and 945 in the oral group. Logistic regression was performed to examine the independent effect of LAI medication on the risk for rehospitalization within the 12-month observation window after controlling for patient and hospital characteristics and propensity score quintile adjustment. The unadjusted odds ratio for rehospitalization risk was 0.80 (confidence interval, 0.65-0.98) for the LAI group compared to the oral group. The adjusted odds ratio was further reduced to 0.78 (confidence interval, 0.63-0.97). Results remained unchanged when the propensity score quintiles were entered into the regression for further adjustment. In a home care setting, patients treated with long-acting antipsychotic agents are at a significantly lower risk for psychiatric rehospitalization than those treated with oral medication. Consequently, LAI home-based treatment for the prevention of schizophrenia relapse may lead to substantial clinical and economic benefits.",
keywords = "Home care, Logistic regression, Long-acting injection, Risperidone, Schizophrenia",
author = "Ju, {Po Chung} and Chou, {Frank Huang Chih} and Lai, {Te Jen} and Chuang, {Po Ya} and Lin, {Yung Jung} and Yang, {Ching Wen Wendy} and Tang, {Chao Hsiun}",
year = "2014",
month = "2",
doi = "10.1097/JCP.0b013e3182a6a142",
language = "English",
volume = "34",
pages = "23--29",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan

AU - Ju, Po Chung

AU - Chou, Frank Huang Chih

AU - Lai, Te Jen

AU - Chuang, Po Ya

AU - Lin, Yung Jung

AU - Yang, Ching Wen Wendy

AU - Tang, Chao Hsiun

PY - 2014/2

Y1 - 2014/2

N2 - We aimed at evaluating the relationship between medication and treatment effectiveness in a home care setting among patients with schizophrenia. Patients with schizophrenia hospitalized between 2004 and 2009 with a primary International Classification of Diseases, Ninth Revision, Clinical Modification code of 295 were identified from Psychiatric Inpatient Medical Claims Data released by the National Health Research Institute in Taiwan. Patients who joined the home care program after discharge and were prescribed long-acting injection (LAI) (the LAI group) or oral antipsychotic medications (the oral group) were included as study subjects. The final sample for the study included 810 participants in the LAI group and 945 in the oral group. Logistic regression was performed to examine the independent effect of LAI medication on the risk for rehospitalization within the 12-month observation window after controlling for patient and hospital characteristics and propensity score quintile adjustment. The unadjusted odds ratio for rehospitalization risk was 0.80 (confidence interval, 0.65-0.98) for the LAI group compared to the oral group. The adjusted odds ratio was further reduced to 0.78 (confidence interval, 0.63-0.97). Results remained unchanged when the propensity score quintiles were entered into the regression for further adjustment. In a home care setting, patients treated with long-acting antipsychotic agents are at a significantly lower risk for psychiatric rehospitalization than those treated with oral medication. Consequently, LAI home-based treatment for the prevention of schizophrenia relapse may lead to substantial clinical and economic benefits.

AB - We aimed at evaluating the relationship between medication and treatment effectiveness in a home care setting among patients with schizophrenia. Patients with schizophrenia hospitalized between 2004 and 2009 with a primary International Classification of Diseases, Ninth Revision, Clinical Modification code of 295 were identified from Psychiatric Inpatient Medical Claims Data released by the National Health Research Institute in Taiwan. Patients who joined the home care program after discharge and were prescribed long-acting injection (LAI) (the LAI group) or oral antipsychotic medications (the oral group) were included as study subjects. The final sample for the study included 810 participants in the LAI group and 945 in the oral group. Logistic regression was performed to examine the independent effect of LAI medication on the risk for rehospitalization within the 12-month observation window after controlling for patient and hospital characteristics and propensity score quintile adjustment. The unadjusted odds ratio for rehospitalization risk was 0.80 (confidence interval, 0.65-0.98) for the LAI group compared to the oral group. The adjusted odds ratio was further reduced to 0.78 (confidence interval, 0.63-0.97). Results remained unchanged when the propensity score quintiles were entered into the regression for further adjustment. In a home care setting, patients treated with long-acting antipsychotic agents are at a significantly lower risk for psychiatric rehospitalization than those treated with oral medication. Consequently, LAI home-based treatment for the prevention of schizophrenia relapse may lead to substantial clinical and economic benefits.

KW - Home care

KW - Logistic regression

KW - Long-acting injection

KW - Risperidone

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84891735927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891735927&partnerID=8YFLogxK

U2 - 10.1097/JCP.0b013e3182a6a142

DO - 10.1097/JCP.0b013e3182a6a142

M3 - Article

C2 - 24145217

AN - SCOPUS:84891735927

VL - 34

SP - 23

EP - 29

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 1

ER -